the detection and quantification of protein-ligand binding interactions is crucial in a number of different areas of biochemical research from fundamental studies of biological processes to drug discovery efforts. Described here is a protocol that can be used to identify the protein targets of biologically relevant ligands (e.g., drugs such as tamoxifen or cyclosporin a) in complex protein mixtures such as cell lysates. the protocol utilizes quantitative, bottom-up, shotgun proteomics technologies (isobaric mass tags for relative and absolute quantification, or itraQ) with a covalent labeling technique, termed stability of proteins from rates of oxidation (sproX). In sproX, the thermodynamic properties of proteins and protein-ligand complexes are assessed using the hydrogen peroxide-mediated oxidation of methionine residues as a function of the chemical denaturant (e.g., guanidine hydrochloride or urea) concentration. the proteome-wide sproX experiments described here enable the ligand-binding properties of hundreds of proteins to be simultaneously assayed in the context of complex biological samples. the proteomic capabilities of the protocol render it amenable to the detection of both the on-and off-target effects of ligand binding. the protocol can be completed in 5 d.
IntroDuctIon
SPROX is a covalent labeling-and mass spectrometry (MS)-based method for evaluating the solution-phase thermodynamic properties of proteins and protein-ligand complexes. SPROX uses the denaturant dependence of the hydrogen peroxide (H 2 O 2 )-mediated oxidation of methionine side chains in proteins ( Fig. 1) to measure the folding free energy of proteins and the K d values of proteinligand complexes 1 . The SPROX protocol and data analysis methods are similar to those in an amide H/D exchange-and MS-based method for taking protein-folding and stability measurements, termed stability of unpurified proteins from rates of H/D exchange (SUPREX) 2, 3 . Both techniques use an MS readout to generate thermodynamic information about the chemical denaturant-induced equilibrium folding or unfolding properties of proteins in solution. The primary difference between SPROX and SUPREX is that SPROX uses the denaturant dependence of the oxidation rates of globally protected methionine residues in a protein ( Fig. 1 ) to generate such thermodynamic information, whereas SUPREX uses the denaturant dependence of the H/D exchange rates of globally protected amide groups in proteins to determine the thermodynamic properties of a protein's folding or unfolding reaction.
The SPROX technique was originally developed with an intact protein readout using matrix-assisted laser desorption/ionization (MALDI) and/or electrospray ionization (ESI)-MS 1 . More recently, the technique has been interfaced with bottom-up liquid chromatography-MS (LC-MS)-based proteomic platforms to facilitate the detection and quantification of protein-ligand binding interactions on the proteomic scale 4, 5 . The protocol described in this work is focused on such proteomic applications of SPROX. The described protocol has been used in several proof-of-principle experiments in which the proteins in a yeast cell lysate were screened for binding to several small-molecule drugs and an enzyme cofactor 4, 5 . These studies demonstrate the utility of the SPROX methodology for detecting both the direct and indirect effects of proteinligand binding interactions in complex biological mixtures such as cell lysates.
Most large-scale and high-throughput protein-ligand binding assays, such as the yeast two-hybrid assay 6 and affinity capture techniques 7 , detect direct binding events. Indirect binding events are more difficult to detect. Such indirect binding events can arise when the direct binding interaction between one protein and a target ligand precludes and/or induces the binding of the first protein to a second protein. Indirect binding interactions go undetected in the yeast two-hybrid assay, and affinity capture techniques are only sensitive to indirect binding interactions in which a direct binding event recruits additional proteins to the protein complex. More recently, a protease protection assay has been developed for the detection of protein-ligand binding interactions on the proteomic scale 8, 9 . Although the protease protection assay is amenable to the detection of both direct and indirect binding interactions in complex protein mixtures, it does not enable quantitative measurements of protein-ligand binding affinities. The ability to detect and quantify both direct and indirect effects of proteinligand binding interactions in complex mixtures is unique to the SPROX methodology.
Experimental design
The methodology presented here involves the use of SPROX with a quantitative, bottom-up, shotgun proteomics platform utilizing isobaric mass tags. The described methodology is designed to identify the protein targets of a specified ligand. The methodology Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation Protein sample preparation. Outlined in this protocol are the steps involved in the SPROX analysis of proteins in a yeast cell lysate. In theory, the same protocol could also be used to analyze proteins in other types of cells and biological tissues. However, an important prerequisite for the method is that the proteins in the biological sample under study be obtained in solution conditions that allow proteins to adopt their native three-dimensional structures. The protocol requires a total of at least 2-3 mg of protein dissolved in ~400 µl of buffer. Half of the protein sample is used for the ( − ) ligand sample, and the other half of the protein sample is used to generate the ( + ) ligand sample, which typically contains micromole quantities of the ligand.
The protocol should be amenable to the analysis of a wide range of different protein ligands. However, ligands that are not stable in H 2 O 2 are likely to be problematic, as are ligands with limited solubility in aqueous buffer systems. The technique requires the preparation of ( + ) ligand samples in which the test ligand is present at several-hundred-micromolar concentrations. Even higher ligand concentrations (e.g., >1 mM) are required in the ( + ) ligand samples to effectively assay the proteinbinding properties of weak-binding ligands (e.g., K d > 100 µM; see ANTICIPATED RESULTS). SPROX analysis. The second part of the experimental workflow outlined in Figure 2 is the SPROX analysis, in which H 2 O 2 is used to selectively oxidize methionine residues in the protein sample as a function of the chemical denaturant concentration. The reaction time and H 2 O 2 concentration are tuned such that the pseudo-firstorder oxidation reaction of an unprotected methionine residue will proceed for ~3-5 half-lives. The oxidation reaction conditions are relatively mild and generate minimal oxidation at other amino acid residues (e.g., Cys and Trp). After the oxidation reactions in each denaturant-containing buffer proceed for the same specified time, they are quenched with the addition of free methionine.
Quantitative, bottom-up shotgun proteomics sample preparation and analysis. The protein material in each denaturantcontaining buffer is submitted to a quantitative, bottom-up shotgun proteomics analysis in which the unoxidized and oxidized methionine-containing peptides are quantified as a function of Figure 1 | Methionine oxidation in the SPROX protocol. (a) Schematic representation of the oxidation primary reactant (i.e., the methionine amino acid side chains in proteins) and the primary product (i.e., the oxidized methionine amino acid side chains) in the H 2 O 2 -mediated oxidation reaction in SPROX. (b) The mechanism by which the methionine amino acid side chains in proteins are oxidized in the SPROX protocol. In the folded protein (represented by the closed circle), methionine residues that are buried in solvent-inaccessible regions of a protein's three-dimensional structure are protected from oxidation. In the unfolded protein (represented by the wavy line), these once-protected methionine residues become exposed to the solvent and are free to react with the H 2 O 2 . The k open and k closed values are the rate constants associated with the protein (or protein domain's) unfolding and refolding reactions, and k ox is the intrinsic exchange oxidation rate of an unprotected (i.e., solvent exposed) methionine residue. Provided that k closed > > k ox , the overall rate at which the globally (or sub-globally) protected methionine residues in proteins are oxidized can be related to the equilibrium constant for the unfolding and refolding reaction of the protein (or protein domain) and ultimately used to evaluate the protein folding free energy as described in ref. [ D e n a t u r a n t ] -L ig a n d + L ig a n d the SPROX buffer denaturant concentration. We have explored the use of several different experimental strategies to quantify the relative abundance of the methionine-containing peptides generated in a proteome-wide SPROX experiment 4, 5, 10, 11 . The isobaric mass tagging strategy described here, which relies on the attachment of isobaric tags to the N-termini and lysine residues of tryptic peptides, has been the most widely used approach in our work to date. The described protocol focuses on the use of the iTRAQ eight-plex, although the tandem mass tag (TMT) six-plex can also be used 4 . The ( − ) and ( + ) ligand samples generated in SPROX (Fig. 2) can be directly analyzed in an LC-tandem mass spectrometry (MS/MS) analysis or be subjected to additional fractionation protocols such as a methionine-containing peptide selection strategy before LC-MS/MS analysis in order to enhance the peptide and protein coverage 5 . The LC-MS/MS system described in this protocol is an Agilent quadrupole-time-of-flight (Q-TOF) mass spectrometer system (Model 6520) equipped with a Chip Cube HPLC interface. However, any LC-MS/MS spectrometer system equipped with the requisite data acquisition and analysis capabilities to perform iTRAQ and/or TMT analyses could be used. As in any bottom-up, shotgun proteomics analysis, the speed and sensitivity of the mass spectrometry system will determine the peptide and protein coverage that can be attained in the SPROX experiment.
Data analysis. The iTRAQ reporter ion intensities obtained from the methionine-containing peptides identified in the proteomics experiment are used to generate chemical denaturation data for the proteins to which they map. The protein-ligand binding assay described here relies on a differential analysis of the chemical denaturation data obtained for a given methionine-containing peptide when the protein sample is analyzed both in the presence and in the absence of the ligand. Proteins that interact with the ligand either directly or indirectly are those identified with methioninecontaining peptides that show transition midpoint (i.e., C 1/2 SPROX value) shifts in the presence of the ligand (Fig. 2) . A sample data set from a typical ligand-binding experiment is provided in the supporting information (Supplementary Data 1-5 ).
MaterIals

REAGENTS
Sample preparation
Yeast In this equation, RI is the refractive index determined by subtracting the refractive index measured for the 0 M buffer from the refractive index measured for the denaturant-containing buffer. Urea-containing buffers can be prepared in a similar manner, except that stock solutions in the 20 mM sodium phosphate buffer, pH 7.4, can be as concentrated as 9.5 M, and the 
EQUIPMENT SETUP LC-MS/MS mass spectrometer system
The LC-MS/MS mass spectrometer system should be set up with the appropriate data acquisition methods to maximize the peptide and protein coverage in a bottom-up shotgun proteomics experiment and to generate iTRAQ reporter ion intensities that are sufficient for accurate quantification. The gradient elution profile used on the LC-MS/MS system employed here is as follows: 2% buffer B over 5 min, 2-15% buffer B over 2.5 min, 15-45% buffer B over 78 min, and then 45-100% buffer B over 10 min. The LC-MS/MS system is equilibrated with 2% buffer B for at least 30 min before sample analysis. The HPLC flow rate is 0.4 µl min − 1 . The capillary voltage is 1,850-1,900 V. The drying gas is 350 °C at a flow rate of 6 liters per min. The skimmer and fragmenter are set to 65 V and 175 V, respectively. The inclusion window width for precursor ions is 4 m/z units. The scan rate is three scans per second in the precursor ion mass spectra and two scans per second in the product ion mass spectra, and four precursor ions are selected for fragmentation per cycle. The collision energy is 3.9 V per 100 m/z with a 2.9 V offset. proceDure protein sample preparation • tIMInG 1 h 1| Thaw a yeast cell pellet in a 2-ml microcentrifuge tube on ice and estimate the volume of the pellet using the volume marks on the tube. Pipette 500 µl of prechilled lysis buffer into the microcentrifuge tube and mix the contents by pipetting the mixture up and down several times and/or by vortexing.  crItIcal step SPROX requires the protein sample to be in native solution conditions; therefore, cell lysis buffers containing denaturing agents such as detergents should be avoided. Some buffers such as HEPES and MOPS also interfere with the oxidation reaction in SPROX and should be avoided. Aprotinin should not be included in the inhibitor mix, as it is a protein-based protease inhibitor that can precipitate with the protein sample in
Step 18 and inhibit the trypsin digestion in
Step 28.
2| Add glass beads to the resuspended cells in the microcentrifuge tube. The volume of glass beads added should be approximately half the volume of the cell suspension noted in Step 1.
3|
Agitate the microcentrifuge tube containing the resuspended cells and glass beads using the Disruptor Genie for 20 s and place the microcentrifuge tube on ice for 1 min.
4| Repeat
Step 3 14 times.
5|
Centrifuge the microcentrifuge tube containing the lysed cells at 14,000g for 10 min at 4 °C.
6|
Transfer the supernatant into a new chilled 1.7-ml microcentrifuge tube. Be careful not to transfer any of the cellular debris and/or glass beads.
? trouBlesHootInG 7| Measure the protein concentration of the lysate using a Bradford assay to ensure that the protein concentration in the lysate is between 6 and 12 mg ml − 1 . Continue immediately to Step 8.
sproX analysis • tIMInG 4 h 8| Divide the lysate into two 180-µl portions.
9| Add 20 µl of the ligand stock solution (prepared in an aqueous buffer or organic solvent such as DMSO depending on the solubility of the ligand) to one portion of the lysate to generate the ( + ) ligand sample of the lysate, and add 20 µl of the aqueous buffer (or organic solvent) used for the ligand stock solution to the other portion of the lysate to generate the ( − ) ligand sample of the lysate (Fig. 2) . 16| Add 200 µl of TCA (100%) to each of the 16 protein samples such that the final TCA concentration in each sample is 16% (wt/vol). ! cautIon TCA is a highly corrosive acid; handle it with appropriate gloves and personal protective equipment.  crItIcal step Methionine will precipitate in acetone. DO NOT use acetone for the protein precipitation. 27| Add 1.5 µl of 200 mM MMTS dissolved in isopropanol to each protein sample (such that the final concentration in each protein sample is 10 mM) and incubate the samples at room temperature for 10 min to alkylate cysteine residues.
17|
Vortex each of the 16 protein samples for 15 s and incubate them on ice for at least 2 h. 
28|
To each protein sample, add a volume of 1 mg ml − 1 porcine pancreas trypsin, typically 1.0-2.5 µl depending on the protein concentration, to achieve a trypsin/protein ratio between 1:20 and 1:100. Incubate the samples at 37 °C with shaking overnight (12-16 h).
29| (Optional) Check for peptides using a MALDI-TOF MS analysis to verify that the trypsin digestion was successful. Combine 1 µl of the digested sample with 9 µl of α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile/0.1% TFA in H 2 O (vol/vol). Spot 2 µl on the MALDI sample plate, allow the solvent to evaporate and collect MALDI mass spectra.
? trouBlesHootInG  pause poInt Digested protein samples can be stored at − 20 °C for a few weeks before proceeding to the iTRAQ labeling.
30|
Allow iTRAQ reagents to reach room temperature. Vortex and centrifuge at 1,000g for 30 s.
31| Dissolve 1.0 U of each iTRAQ tag from the iTRAQ 8-plex kit in 100 µl of isopropyl alcohol.
32|
Label the protein samples in each set of eight denaturant-containing SPROX buffers with a different iTRAQ tag by combining the digested protein sample with 50 µl (0.5 U) of the corresponding iTRAQ tag (Fig. 2) prepared in Step 31. Allow the samples to react for 2 h at room temperature.  crItIcal step Check the pH of each sample using 0.5 µl of sample and a pH paper to ensure that the pH is 7.5 or greater. A pH of 7.5 or greater is required for optimal iTRAQ labeling efficiency. If the pH is less than 7.5, add up to 5 µl of 0.5 M TEAB buffer until the pH is between 7.5 and 8.5. The concentration of organic solvent in each sample must be at least 60% (vol/vol).
33|
Combine the eight different iTRAQ-labeled samples from the ( − ) ligand SPROX analysis into one microcentrifuge tube, and combine the eight different iTRAQ-labeled samples from the ( + ) ligand SPROX analysis into another microcentrifuge tube (Fig. 2) .  pause poInt Samples can be stored at − 20 °C or colder for at least several weeks.
34| Prepare the ( − ) and ( + ) ligand SPROX samples from
Step 33 for LC-MS/MS analysis using the C18 MacroSpin columns (Box 1) or using the Pi 3 Met resin and C18 medium (Box 2). The use of the Pi 3 Met resin can significantly increase the peptide and protein coverage observed in the experiment (see ANTICIPATED RESULTS).  crItIcal step Make sure to remove any salts and detergents from the sample by performing
Step 34 before LC-MS/MS analysis.
35| Perform at least three replicate LC-MS/MS analyses of the ( − ) and ( + ) ligand samples prepared in
Step 34. Load ~1-10 µg of total peptide on the column, on the basis of the total protein concentration determined in Step 25. If the methionine enrichment protocol is used (Box 2), it is still necessary to perform at least one LC-MS/MS analysis of the ( − ) and ( + ) ligand samples that were prepared using the C18 Cleanup (Box 1) but were not enriched for methioninecontaining peptides using the Pi 3 Met resin.
? trouBlesHootInG Data analysis • tIMInG 5 h  crItIcal A sample data set that has been analyzed according to Steps 36-52 is included in the supplementary Data 1-5.
36| Search the LC-MS/MS files generated in
Step 35 using appropriate software such as Spectrum Mill, and export the following search results into Excel: file name, peptide sequence, identification score, modification sites (e.g., oxidized methionine, iTRAQ label and so on), retention time, protein accession number and/or name, and the eight iTRAQ reporter ion intensities (without any applied normalization). The oxidation reaction conditions in SPROX (Steps 14 and 15) are tuned such that the thioether group in the side chain of methionine residues in proteins is the primary site of oxidation in SPROX. Oxidation at other amino acid side chains that are susceptible to oxidation (e.g., Cys and Trp) is generally not observed in the SPROX experiment, because the oxidation reaction rates associated with these other amino acid side chains is much slower than that of the methionine side chain. To ensure that there are no major oxidation products involving other amino acid residues, the LC-MS/MS data searches can include potential oxidation sites on various other amino acids (e.g., Cys and Trp).  crItIcal step The LC-MS/MS data searches for the samples prepared using the Pi 3 Met resin require that the identified peptides contain a methionine residue. Other key search parameters for all the LC-MS/MS data include fixed modifications of MMTS on cysteine, iTRAQ 8-plex on N-terminus and lysine, and variable modification of oxygen on methionine.
? trouBlesHootInG
Box 1 | C18 cleanup • tIMInG 1.5 h
The following steps describe the use of commercially available MacroSpin columns with silica C18 to concentrate and desalt the iTRAQ-labeled peptide mixtures generated in the SPROX protocol. This concentration and desalting step is crucial to the success of the LC-MS/MS analysis. This is a modified version of the manufacturer's protocol. 1. Add 1.4 ml of 0.1% (vol/vol) TFA to 40-80 µl of ( − ) and ( + ) ligand samples from Step 33, which should each contain between 30 and 300 µg of total peptide. This should decrease the concentration of the organic solvent in each sample to ≤5%. Check the pH of the sample using 0.5 µl of sample and pH paper. If the pH is greater than 3, add 1-5 µl of 5% (vol/vol) TFA to decrease the pH to 2-3.
2. Obtain two columns of C18 resin, one each for the ( − ) and ( + ) ligand samples. 3. Add 400 µl of acetonitrile or methanol to each C18 column and vortex to wet the column. Place each column in a 2-ml centrifuge collection tube and centrifuge at 2,500g for 30 s at room temperature. Dispose of the column flow through. 4. Add 400 µl of 0.1% (vol/vol) TFA to the C18 column and centrifuge at 2,500g for 30 s at room temperature. Dispose of the column flow-through. 5. Centrifuge the sample through the prepared C18 column in three ~500-µl aliquots at 2,500g for 30 s at room temperature. 6. Add 400 µl of 0.1% (vol/vol) TFA to the C18 column and centrifuge at 2,500g for 30 s at room temperature. Dispose of the column flow through. 7. Repeat step 6 twice. 8. Obtain new collection tubes for C18 columns. Add 50 µl of 30% acetonitrile/0.1% TFA (vol/vol) and centrifuge at 2,500g for 30 s. The column elution contains peptides. 9. Repeat step 8 using 70% acetonitrile/0.1% TFA (vol/vol). 10. Place the samples on a SpeedVac Concentrator for ~30 min or until the sample volume is less than or equal to 50 µl. 11. Add 100-130 µl of 0.1% (vol/vol)TFA to each sample to increase the total sample volume.  crItIcal step Ensure that the total percentage of the organic solvent is less than 10% before LC-MS/MS analysis.  pause poInt The samples can be stored at 4 °C for several days.
Box 2 | Enrichment of methionine-containing peptides with Pi 3 Met resin • tIMInG 8 h
The following steps describe the use of a commercially available Pi 3 methionine reagent kit to increase the number of methioninecontaining peptides identified and quantified in the LC-MS/MS analysis of the iTRAQ-labeled peptide mixtures generated in the SPROX experiment. The final steps in this protocol include a C18-sample cleanup procedure that is similar to that in Box 1 but uses the C18 medium provided with the Pi 3 methionine reagent kit. This is a modified version of the manufacturer's protocol.
sample preparation 1. Take between 160 and 240 µl of the ( − ) and ( + ) ligand samples (each containing up to a maximum of 100 µg total peptide) from
Step 33, and reduce the sample volumes to <50 µl using a SpeedVac concentrator. 2. Add H 2 O to achieve a final volume of 75 µl in each sample. 3. Add 25-30 µl of 100% (glacial) acetic acid to each sample to adjust the pH to 2-3. Mix each sample thoroughly. ! cautIon Glacial acetic acid is volatile/flammable and should be handled under a fume hood. Glacial acetic acid is also a severe health hazard, and proper personal protective equipment should be worn. 37| Sum and average all the iTRAQ reporter ion intensities for each peptide entry in the Excel file containing the LC-MS/MS search results.
38|
For each peptide entry in the Excel file, divide each of the eight reporter ion intensities by the average reporter ion intensity for that peptide to generate a set of so-called N1-normalized iTRAQ reporter ion intensities for each peptide. This N1-normalization procedure accounts for reporter ion intensity differences that are typically observed from peptide to peptide.
39|
Filter the peptides in the Excel file to include peptide entries from the ( − ) ligand samples with high summed iTRAQ intensity values (typically summed values >1,000) and sequences identified with high confidence (e.g., false discovery rate (FDR) <1%) that do not contain a methionine residue.
40| Average all the N1-normalized values obtained for each iTRAQ reporter ion in
Step 39. The average N1-normalized values obtained for each iTRAQ reporter ion will be used as the N2-normalization factors for the second normalization in Step 42. It is also important to check the distribution of the N1-normalized values for each iTRAQ reporter ion to ensure that it is centered close to the average and approximates a normal distribution with a coefficient of variation of ~30%. See Figure 3 for typical results. In theory, the N1-normalized values from all the non-methionine-containing peptides and the resulting N2-normalization factors for each of the iTRAQ reporter ions should be close to 1.0. In practice, the N1-normalized values and resulting N2-normalization factor for a specific iTRAQ reporter ion can be shifted away from 1 owing to differential amounts of protein being precipitated and re-dissolved in Steps 16-20 and/or because of differential yields of iTRAQ-labeled peptide products in Step 32. N2-normalization factors are typically between 0.8 and 1. methionine residue. Divide the N1-normalized values for each of these methionine-containing peptides by the appropriate N2-normalization factor that was determined in
Step 40 in order to generate a set of N2-normalized iTRAQ reporter ion intensities for each methionine-containing peptide. This N2-normalization procedure accounts for systematic errors in the experiment that might affect the relative iTRAQ reporter ion intensities observed for a given methioninecontaining peptide (e.g., owing to differential amounts of protein being precipitated and re-dissolved in Steps 16-20 and/or because of differential yields of iTRAQ-labeled peptide products in Step 32).
43| Repeat
Step 42 using the LC-MS/MS data generated on the ( + ) ligand sample.
44| Make a new Excel spreadsheet containing the following data in consecutive columns: the identified peptide sequences in the ( − ) ligand sample that contain a methionine residue and have summed iTRAQ reporter ion intensities >1,000; the name of the protein to which each peptide maps; the identification score for each peptide identification; the retention time of the peptide; and the eight N2-normalized iTRAQ reporter ion intensity values determined in Step 42. Ensure that the oxidized methionine residues in the peptide sequences are clearly distinguished from unoxidized methionine residues (i.e., use m(ox) and M, not m and M), and that all other one-letter amino acid abbreviations are capitalized. Some software programs, such as Spectrum Mill, indicate the presence of specific amino acid modification with lowercase letters (e.g., 'q' for a deaminated glutamine). All such lowercase letters should be replaced with capital letters. Export the data from this new Excel spreadsheet into a tab-delimited text file (i.e., a '*.txt' file).
45| Repeat
Step 44 using the ( + ) ligand sample data.
46| Use Runcompare to average the N2-normalized data generated from replicate product ion mass spectra collected on the same peptide and to determine the methionine-containing peptides that are common to both the ( − ) and ( + ) ligand samples. The average retention time and score for each peptide replicate is also included in the Runcompare output files.
47|
Open the newly created matched file in Excel and examine the distribution of the N2-normalized values for the iTRAQ tags corresponding to the low and high denaturant concentration for the unoxidized methionine-containing peptides that are common to both the ( − ) and ( + ) ligand samples. The distribution of N2-normalized values for the tag corresponding The horizontal dotted line represents the N2-normalized value that best separates the two distributions in a. Actual SPROX data sets for methionine-containing peptides are generally represented as bar graphs (Fig. 6) , and they have transition midpoints that are shifted to higher or lower denaturant concentrations depending on the stability of the protein to which the peptide maps.
to the high denaturant concentration is typically centered around 0.5, and the distribution of N2-normalized iTRAQ values for the tag corresponding to the lowest denaturant concentration is typically centered around 1.5. See Figure 4a for a typical result. The point at which the distributions cross (typically ~1) is the N2-normalized value expected at the transition midpoint of a peptide's chemical denaturation data set (Fig. 4b) .
48| Repeat
Step 47 for the oxidized methionine-containing peptides. In this case, the distribution of N2-normalized values for the tag corresponding to the high denaturant concentration should be centered around 1.5, and the distribution of iTRAQ_N2 values for the tag corresponding to the lowest denaturant concentration should be centered around 0.5. The point at which the distributions cross is the approximate transition midpoint of a theoretical curve (typically ~1). 51| Determine what range of differences encompass ~70% of the data, and then filter the differences to identify peptides that have at least two consecutive differences outside the specified range. Copy these peptides into a new worksheet labeled 'Potential Hits' .
52|
The chemical denaturation data (i.e., the N2-normalized iTRAQ reporter ion intensities) for each peptide in the 'Potential Hits' worksheet should be visually inspected to determine which peptides have significant transition midpoint differences ( > 0.5 M for GdmCl or >1 M for urea) in the ( − ) and ( + ) ligand samples. In the visual inspection of the chemical denaturation data, C 1/2 SPROX values are assigned to be the chemical denaturant concentration at which the N2-normalized iTRAQ values transition from the pre-to the post-transition baseline (Figs. 4b and 5) . Normally, the denaturant concentrations corresponding to the N2-normalized iTRAQ values flanking the transition are averaged, and the average value is assigned as the transition midpoint. However, if there is an N2-normalized iTRAQ value of 1.0 ± 0.1 at the transition, then that denaturant concentration is assigned as the transition midpoint. When multiple N2-normalized iTRAQ values of 1.0 ± 0.1 exist at the transition, the denaturant concentrations at all points are averaged, and this average value is assigned as the transition midpoint. Chemical denaturation data sets in which more than one data point (i.e., one N2-normalized iTRAQ value) is not >1.0 or <1.0 in the pre-and post-transition baselines, respectively, are classified as 'poor quality' and not assigned a transition midpoint. When only a single normalized reporter ion intensity is inconsistent with the expected pre-and posttransition baseline values, the outlying value is typically removed from the data set and the remaining seven values are used in the visual inspection to assign the transition midpoint. When no transition is observed (i.e., the N2-normalized iTRAQ reporter ion values obtained for a methionine-containing peptide are randomly distributed around 1.0), the peptide may not be derived from a globally protected region of protein structure or the transition midpoint may be greater than the largest denaturant concentration probed.
? trouBlesHootInG Troubleshooting advice can be found in table 1. Be sure to apply N2-normalization procedure in
Step 42
The distribution for a given iTRAQ tag is not centered at 1 and distribution is wide (i.e., relative s.d. = >40%)
• 
antIcIpateD results
The peptide and protein coverage in a proteome-wide SPROX experiment will depend on the protein sample and on the LC-MS/MS instrumentation and data acquisition methods used in the shotgun proteomics analysis. For a specific protein to be assayed for ligand binding, a methionine-containing peptide from the protein must be successfully identified and quantified in both the ( − ) and ( + ) ligand samples. Therefore, only a subset of the peptides and proteins identified in the LC-MS/MS analyses are included in the assay. In a typical bottom-up proteomics experiment, ~20% of the identified peptides are methionine-containing peptides, and they map to about 30% of the identified proteins 4 . The methionine-containing peptide enrichment protocol typically increases the fraction of methionine-containing peptides to >70% (refs. 5,15) . In triplicate LC-MS/MS analyses of SPROX samples both before and after methionine-containing peptide enrichment, typically ~200 methionine-containing peptides from ~100 proteins in a yeast cell lysate can be assayed using the Q-TOF instrument and data-dependent acquisition methods outlined in this protocol. As many as ~400 methionine-containing peptides from ~200 yeast proteins can be assayed by increasing the number of LC-MS/MS analyses performed on the methionine-containing peptide-enriched samples from 3 to 12. The use of faster and more sensitive LC-MS/MS instrumentation is also likely to increase the number of peptides and proteins that can be effectively assayed for ligand binding in the SPROX experiment.
Approximately 30-40% of the methionine-containing peptides assayed in a SPROX experiment yield SPROX data sets with clearly defined pre-and post-transition baselines and easily assigned transition midpoints (Fig. 6a) . Another 30-40% of the identified methionine-containing peptides yield SPROX data sets in which one N2-normalized value must be overlooked in order to establish the pre-and post-transition baselines and assign a transition midpoint (Fig. 6) . Approximately 30% of the identified methionine-containing peptides yield poor quality SPROX data sets that do not have the assumed data set structure and thus must be eliminated from the analysis.
Hit proteins are identified as those with peptides that have significant ligand-induced C 1/2 SPROX value shifts (>0.5 M GdmCl or >1.0 M urea) to either a higher or lower chemical denaturant concentration (Fig. 6b) . Such hit proteins are expected to be targets (either direct or indirect) of the ligand under study. The magnitude of a protein's C 1/2 SPROX value shift will depend on the binding free energy, which is a function of both the inherent affinity of the protein-ligand binding interaction(s) responsible for the hit and the free ligand concentration used in the SPROX analysis 5 . In our proof-of-principle studies, a C 1/2 SPROX value shift of 1.0 M urea was observed for the binding of NAD + to alcohol dehydrogenase, yielding a K d value of 6 µM (ref. 5) , and a C 1/2 SPROX value shift of 1.5 M GdmCl was observed for the tight binding interaction between cyclophilin and cyclosporin, yielding a K d value of 26 nM (ref. 4) .
The FDR of hit proteins will vary depending on the magnitude of the observed C 1/2 SPROX value shift and how many iTRAQ tag differences are used to identify the protein hit in Step 52. On the basis of a comparison of two ( − ) ligand sample analyses of the proteins in a yeast cell lysate, we have estimated the FDR to be ~4% for protein hits identified with only two consecutive iTRAQ tag differences and ≤1% for protein hits identified with three or four consecutive iTRAQ tag differences 5 . The 
